Inogen, Inc.
INGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.31 | 0.29 | 0.19 | -0.09 |
| FCF Yield | 1.95% | 2.29% | -9.36% | -2.84% |
| EV / EBITDA | -576.91 | 115.15 | -10.42 | -24.47 |
| Quality | ||||
| ROIC | -2.82% | -2.35% | -3.07% | -4.95% |
| Gross Margin | 50.82% | 44.80% | 44.21% | 45.32% |
| Cash Conversion Ratio | -0.41 | -1.05 | 2.72 | 0.31 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.91% | -0.56% | -2.70% | -3.81% |
| Free Cash Flow Growth | -3.33% | 125.91% | -172.70% | -387.84% |
| Safety | ||||
| Net Debt / EBITDA | 399.34 | -92.92 | 13.02 | 18.85 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.81 | 2.10 | 1.98 | 1.76 |
| Cash Conversion Cycle | 21.24 | 29.46 | 45.29 | 50.67 |